Adamis Pharmaceuticals Announces Third Quarter 2019 Financial Results and Business Update


You May Also Like

Horizon Pharma plc to Participate in Investor Conferences in November

DUBLIN, Ireland, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical ...

ObsEva Appoints Elke Bestel as Chief Medical Officer and Jean-Pierre Gotteland as Chief Scientific Officer

PLAN-LES-OUATES, Switzerland, Sept. 22, 2015 (GLOBE NEWSWIRE) -- ObsEva, a Swiss biopharmaceutical company developing ...